DEFA14A

 

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.)

 

 

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Under §240.14a-12

Eliem Therapeutics, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply)

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 


LOGO

 

PROXY TABULATOR, P.O. BOX 8016, CARY, NC 27512-9903

  

Eliem Therapeutics, Inc.

Important Notice Regarding the Availability

of Proxy Materials

 

Stockholders Meeting to be held on

May 19, 2022

 

For Stockholders of record as of March 25, 2022

 

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

To view the proxy materials, and to obtain directions to attend the meeting, go to: www.proxydocs.com/ELYM

 

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

 

Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.

 

LOGO

 

LOGO  

 

For a convenient way to view proxy materials and VOTE go to

www.proxydocs.com/ELYM

 

Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions.

 

      LOGO
 

 

If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before May 09, 2022.

  

To order paper materials, use one of the following methods.

 

 

LOGO

 

 

    

  

 

LOGO

    

 

LOGO

INTERNET

www.investorelections.com/ELYM

    

TELEPHONE

(866) 648-8133

 

    

  

* E-MAIL

paper@investorelections.com

When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above.

     * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.

 

 

Eliem Therapeutics, Inc.

 

Meeting Type:   Annual Meeting of Stockholders

Date:    Thursday, May 19, 2022

Time:   10:00 AM, Pacific Time

Place:   Annual Meeting to be held live via the internet - please visit

  www.proxydocs.com/ELYM for more details

 

You must register to attend the meeting online and/or participate at www.proxydocs.com/ELYM

 

SEE REVERSE FOR FULL AGENDA

 


Eliem Therapeutics, Inc.

Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

FOR ON PROPOSALS 1 AND 2

PROPOSAL

 

1.

To elect three nominees for director named herein to the Board of Directors to hold office until the 2025 Annual Meeting of Stockholders.

1.01 Robert Azelby

1.02 Judith Dunn

1.03 Adam Rosenberg

 

2.

To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.

 

3.

To conduct any other business properly brought before the meeting.